Shanghai ERP peptide Biotechnology
Shanghai ERP peptide Biotechnology's purity-focus record is strongest in Tirzepatide and Retatrutide, where deeper, recent identity/purity results are steadier after earlier misses. The catalog remains dispersed because HGH and TB-500 show recent purity/fill failures, with uneven batch IDs limiting lot-level confidence.
ERP’s public footprint splits across WordPress, BeikeShop, and a Louise wholesale subdomain, with placeholder policies and mismatched contacts. The report traces Genesis-branded vials, crypto payment rails, a New Hampshire fulfillment clue, and a documented endotoxin dispute.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Shanghai ERP peptide Biotechnology rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 4 Aug 2026 | Pass | Retatrutide Shanghai ERP peptide Biotechnology | lab name | View COA | |||
| 3 Aug 2026 | Pass | HGH Shanghai ERP peptide Biotechnology | lab name | View COA | |||
| 30 Jul 2026 | Pass | Retatrutide Shanghai ERP peptide Biotechnology | lab name | View COA | |||
| 30 Jul 2026 | Pass | Retatrutide Shanghai ERP peptide Biotechnology | lab name | View COA | |||
| 22 Jul 2026 | Pass | Retatrutide Shanghai ERP peptide Biotechnology | lab name | View COA | |||
| 22 Jul 2026 | Fail | TB-500 Shanghai ERP peptide Biotechnology | lab name | View COA | |||
| 21 Jul 2026 | Pass | Tesamorelin Shanghai ERP peptide Biotechnology | lab name | View COA | |||
| 20 Jul 2026 | Pass | Retatrutide Shanghai ERP peptide Biotechnology | lab name | View COA | |||
| 13 Jul 2026 | Pass | Retatrutide Shanghai ERP peptide Biotechnology | lab name | View COA | |||
| 13 Jul 2026 | Pass | Tirzepatide Shanghai ERP peptide Biotechnology | lab name | View COA | |||
About Shanghai ERP peptide Biotechnology test results from Finnrick
Shanghai ERP peptide Biotechnology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 8 peptides and 112 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Shanghai ERP peptide Biotechnology peptides in this dataset are Tirzepatide (18 tests) and BPC-157 (6 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 112 recent tests.